Back

Atrial fibrillation burden characteristics in heart failure patients with reduced versus preserved ejection fraction as detected by insertable cardiac monitors.

11 May 2024 (11:57 - 12:06)
Organised by: Logo
Congress Presentation Part of: Arrhythmias in heart failure Heart Failure in Atrial Fibrillation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Shantanu Sarkar

Moundsview (United States of America)

6 More presentations in this session

Presentation thumbnail
Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac device
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Fusion CRT pacing and LA reverse remodeling: the key for low incidence of atrial fibrillation in HF patients
Doctor C. Vacarescu (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Characterizing atrial fibrillation in patients with and without heart failure and across the ejection fraction spectrum: incidence, prevalence, and treatment strategies
Doctor V. Valente (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Heart failure detection from electrocardiogram using artificial intelligence
Doctor A. Ranjbar (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Change of natriuretic peptides over time predicts new development of atrial fibrillation in at risk population
Doctor C. Powell (Cork, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias in heart failure
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 11:57 CET
You may be interested in
thumbnail
Congress Presentation
Incidence of atrial fibrillation detected by an insertable cardiac monitor in a large real-world cohort of heart failure patients with reduced and preserved ejection fraction
thumbnail
Congress Session
Arrhythmias in heart failure
thumbnail
Congress Presentation
Characterizing atrial fibrillation in patients with and without heart failure and across the ejection fraction spectrum: incidence, prevalence, and treatment strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources